Gelstat Corp. Stock Analysis GSAC
GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Miami, Florida. The Company’s products include Intelligent Control Automation System (ICAS), Encrypted Control Device (ECD), and Variable Base Encryption Compression (VBEC). ICAS integrates control, telemetry, video, and communications in a seamless interface designed to control complex processes with limited human resources. ICAS offers customized automation solutions that align with the specific requirements of industrial processes without disrupting their current operations. ECD is a multi-platform input/output solution designed to maintain secure control management. VBEC is an efficient compression protocol to enable transmission of AES-256 encryption blocks fragmented into smaller length packets compatible with existing 2.4 GHz airwaves. The firm's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security.
Read More Gelstat Corp (GSAC) Chart
Key Statistics of Gelstat Corp (GSAC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1.48MP/E Ratio (TTM)
-52 Week Range
Market Cap
1.31MAvg. Volume
2.00MDividend Yield
-Financial Metrics & Statements of Gelstat Corp (GSAC)
FAQ's for Gelstat Corp (GSAC)
- According to Musaffa’s Shariah screening methodology, Gelstat Corp (GSAC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.